A substantial advancement in glucose management is emerging with the introduction of tirzepatide at a dosage of 45mg. This new version builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, and https://socialicus.com/story6816771/revolutionary-introduction-tirzepatide-dose-for-blood-sugar-regulation